Published online April 3, 2006
PEDIATRICS Vol. 117 No. 4 April 2006, pp. 999-1008 (doi:10.1542/10.1542/peds.2005-1201)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luman, E. T.
Right arrow Articles by Seward, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luman, E. T.
Right arrow Articles by Seward, J. F.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Uptake of Varicella Vaccination Among Young Children in the United States: A Success Story in Eliminating Racial and Ethnic Disparities

Elizabeth T. Luman, PhD, Pamela L. Y. H. Ching, SD, Aisha O. Jumaan, PhD and Jane F. Seward, MBBS, MPH

National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia

OBJECTIVE. To examine uptake of varicella vaccine, a live attenuated vaccine licensed in 1995 and recommended in 1996 for routine vaccination of US children 12 to 18 months of age.

METHODS. Data were for 178616 children (19–35 months of age) and were collected in the 1997 to 2004 National Immunization Survey. The main outcome measures were estimated varicella vaccine coverage from 1997 to 2004, coverage among susceptible children (ie, those without a history of varicella disease), racial/ethnic disparities, risk factors for nonvaccination, missed opportunities to vaccinate simultaneously with other recommended vaccines, and projected increases in coverage after elimination of missed opportunities for simultaneous vaccination.

RESULTS. Varicella vaccine coverage rates increased from 26% in 1997 to 87% in 2004. State-specific coverage rates increased 44 to 80 percentage points and were >80% in 42 states and >90% in 13 states by 2004. Coverage among susceptible children increased from 62% in 1999 to 88% in 2004. From 1998 onward, no statistically significant differences in coverage were found between white and black children, whereas Hispanic children had higher coverage rates than white children in 1998 to 2001 and 2004. Risk factors for undervaccination included living in the Midwest region, living in a household with >1 child, living in nonmetropolitan areas, living below the poverty level, having a mother who did not have a college degree, and having public providers. If missed opportunities for simultaneous vaccination had been eliminated, then coverage rates would have increased from 58% to 94% in 1999 and from 87% to 96% in 2004.

CONCLUSIONS. Uptake of varicella vaccine has been steady and is an example of successful elimination of racial and ethnic disparities. Additional focus should be placed on reducing missed opportunities for simultaneous vaccination, improving coverage in rural areas and the Midwest region, and closing remaining gaps related to maternal education, provider type, and multiple-children households.


Key Words: varicella vaccine • racial disparities • vaccination coverage • immunization

Abbreviations: CDC—Centers for Disease Control and Prevention • NIS—National Immunization Survey • MSA—metropolitan statistical area • MMR—measles-mumps-rubella • Hib—Haemophilus influenzae type b • DTaP—diphtheria-tetanus-acellular pertussis • VFC—Vaccines for Children • SCHIP—State Children's Health Insurance Program


Accepted Aug 19, 2005.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
M. Marin, H. C. Meissner, and J. F. Seward
Varicella Prevention in the United States: A Review of Successes and Challenges
Pediatrics, September 1, 2008; 122(3): e744 - e751.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. V. Groom, M. L. Washington, P. J. Smith, and R. T. Bryan
Underimmunization of American Indian and Alaska Native Children
Pediatrics, May 1, 2008; 121(5): 938 - 944.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. B. Fishbein, K. R. Broder, L. Markowitz, and N. Messonnier
New, and Some Not-so-New, Vaccines for Adolescents and Diseases They Prevent
Pediatrics, January 1, 2008; 121(Supplement_1): S5 - S14.
[Abstract] [Full Text] [PDF]